Which drug is approved for weight loss in Australia?

Liraglutide, marketed under the brand name Saxenda, is approved in Australia for weight loss. It is a GLP-1 receptor agonist that works by regulating appetite, increasing feelings of fullness, and reducing caloric intake, which can significantly aid in weight management for individuals with obesity or overweight conditions.

The approval of Liraglutide for weight loss is based on clinical studies demonstrating its efficacy in achieving weight loss when combined with a reduced-calorie diet and increased physical activity. This medication not only helps individuals lose weight but can also contribute to improvements in weight-related health conditions, making it a viable option for those who are struggling with obesity.

Other drugs listed, such as Sibutramine, have been discontinued in many jurisdictions due to safety concerns and adverse effects. Orlistat is also available for weight management; however, its approval status may vary based on the specific formulation and regulatory changes in Australia. PhenQ is a dietary supplement rather than a prescribed medication and lacks formal approval for weight loss in Australia, which makes Liraglutide the most suitable and recognized choice among the options provided.